{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:30:47Z","timestamp":1786681847610,"version":"build-2736575974"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The presence of multiple rare Mendelian disorders in a single patient may mask clinical recognition when phenotypes overlap. We describe a patient with longstanding myotonia congenita due to a\n                      <jats:italic>CLCN1<\/jats:italic>\n                      variant in whom an incidental discovery of severe hypocalcemia led to the diagnosis of\n                      <jats:italic>GNAS<\/jats:italic>\n                      -related pseudohypoparathyroidism (PHP). Exome reanalysis also identified an incidental homozygous pathogenic\n                      <jats:italic>CYP1B1<\/jats:italic>\n                      variant associated with autosomal recessive glaucoma.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 23-year-old man born to consanguineous parents was referred for management of chronic myotonia congenita, manifested by delayed motor milestones, frequent falls, contractures, and muscle hypertrophy. Electrophysiological assessment demonstrated myotonic discharges, and whole-exome sequencing (WES) identified a homozygous\n                      <jats:italic>CLCN1<\/jats:italic>\n                      splice-site variant (NM_000083.3:c.1167-10T&amp;gt;C) known to cause myotonia congenita. During subsequent evaluation, he was found to have severe hypocalcemia, hyperphosphatemia, markedly elevated parathyroid hormone, basal ganglia and dentate calcifications, brachydactyly, subcutaneous calcifications, and mild hypothyroidism, raising suspicion for PHP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Genetic and ophthalmologic findings<\/jats:title>\n                    <jats:p>\n                      Reanalysis of WES data demonstrated a heterozygous frameshift\n                      <jats:italic>GNAS<\/jats:italic>\n                      variant (NM_080425.4:c.2494_2497delCTGA) and a homozygous\n                      <jats:italic>CYP1B1<\/jats:italic>\n                      variant (NM_000104.4:c.182G&amp;gt;A; p.Gly61Glu) in addition to the\n                      <jats:italic>CLCN1<\/jats:italic>\n                      defect. Sanger sequencing confirmed all three variants. The\n                      <jats:italic>CYP1B1<\/jats:italic>\n                      finding prompted glaucoma-specialist evaluation. Visual acuity was 20\/22 in the right eye and 20\/25 in the left eye; intraocular pressures were 8 and 12 mmHg, respectively. The corneas were clear, cup-to-disc ratios were 0.4 and 0.5, and average retinal nerve fiber layer thicknesses were 74 and 75 \u00b5m. No definite glaucomatous damage was identified, and the patient was classified as a glaucoma suspect. After treatment with calcium, calcitriol, and ergocalciferol, serum calcium improved, parathyroid hormone levels declined, creatine kinase normalized, and the patient reported improved muscle stiffness and function.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case demonstrates two clinically expressed Mendelian disorders together with a third actionable molecular finding. It highlights the importance of careful phenotyping, molecular testing, and cautious genotype-phenotype interpretation, particularly in consanguineous populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1850762","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:22:44Z","timestamp":1786681364000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Three pathogenic molecular findings in a patient with myotonia congenita, pseudohypoparathyroidism, and a glaucoma-suspect phenotype"],"prefix":"10.3389","volume":"17","author":[{"given":"Noha N.","family":"Mukhtar","sequence":"first","affiliation":[{"name":"Department of Medicine, King Faisal Specialist Hospital & Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deema","family":"Alturki","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Faisal Specialist Hospital & Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allianah","family":"Benito","sequence":"additional","affiliation":[{"name":"Molecular Endocrine Section, Research and Innovation, King Faisal Specialist Hospital & Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balgees","family":"Alghamdi","sequence":"additional","affiliation":[{"name":"Molecular Endocrine Section, Research and Innovation, King Faisal Specialist Hospital & Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Alshehri","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, King Faisal Specialist Hospital & Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali S.","family":"Alzahrani","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Faisal Specialist Hospital & Research Centre","place":["Riyadh, Saudi Arabia"]},{"name":"Molecular Endocrine Section, Research and Innovation, King Faisal Specialist Hospital & Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26887","article-title":"Guidelines on clinical presentation and management of nondystrophic myotonias","volume":"62","author":"Stunnenberg","year":"2020","journal-title":"Muscle Nerve"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt133","article-title":"Non-dystrophic myotonia: prospective study of objective and patient reported outcomes","volume":"136","author":"Trivedi","year":"2013","journal-title":"Brain"},{"key":"B3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0065-2660(08)01002-X","article-title":"Myotonia congenita","volume":"63","author":"Lossin","year":"2008","journal-title":"Adv Genet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab060","article-title":"Molecular definition of pseudohypoparathyroidism variants","volume":"106","author":"J\u00fcppner","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","article-title":"Pseudohypoparathyroidism: an example of \"Seabright-Bantam syndrome","volume":"30","author":"Albright","year":"1942","journal-title":"Endocrinology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-0625","article-title":"Inactivating PTH\/PTHrP signaling disorders (iPPSDs): evaluation of the new classification in a multicenter large series of 544 molecularly characterized patients","volume":"184","author":"Pereda","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1159\/000508985","article-title":"Recommendations for diagnosis and treatment of pseudohypoparathyroidism and related disorders: an updated practical tool for physicians and patients","volume":"93","author":"Mantovani","year":"2020","journal-title":"Horm Res Paediatr"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2021.104378","article-title":"Genetics in primary congenital glaucoma: implications in disease management and counseling","volume":"65","author":"Leysen","year":"2022","journal-title":"Eur J Med Genet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11072048","article-title":"Geographical variability in CYP1B1 mutations in primary congenital glaucoma","volume":"11","author":"Shah","year":"2022","journal-title":"J Clin Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.53888","article-title":"Consanguineous marriage and its association with genetic disorders in Saudi Arabia: a review","volume":"16","author":"Khayat","year":"2024","journal-title":"Cureus"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.15537\/1658-3175.4167","article-title":"Regional variations in the prevalence of consanguinity in Saudi Arabia","volume":"28","author":"El-Mouzan","year":"2007","journal-title":"Saudi Med J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4314\/ahs.v14i2.5","article-title":"Is consanguinity prevalence decreasing in Saudis?: a study in two generations","volume":"14","author":"Warsy","year":"2014","journal-title":"Afr Health Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2008.39","article-title":"In tandem analysis of CLCN1 and SCN4A greatly enhances mutation detection in families with non-dystrophic myotonia","volume":"16","author":"Trip","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2013.58","article-title":"A large cohort of myotonia congenita probands: novel mutations and a high-frequency mutation region in exons 4 and 5 of the CLCN1 gene","volume":"58","author":"Brugnoni","year":"2013","journal-title":"J Hum Genet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04304-w","article-title":"Clinical exome sequencing in neuromuscular diseases: an experience from Turkey","volume":"41","author":"B\u00f6rkl\u00fc-Y\u00fccel","year":"2020","journal-title":"Neurol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","volume":"42","author":"Landrum","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-020-02199-3","article-title":"The Human Gene Mutation Database (HGMD\u00ae): optimizing its use in a clinical diagnostic or research setting","volume":"139","author":"Stenson","year":"2020","journal-title":"Hum Genet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.32346","article-title":"Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification","author":"Adegbite","year":"2008","journal-title":"Am J Med Genet A"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1451","article-title":"Progressive osseous heteroplasia: a model for the imprinting effects of GNAS inactivating mutations in humans","volume":"95","author":"Lebrun","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14700","article-title":"Infantile-onset osteoma cutis with pseudopseudohypoparathyroidism","volume":"46","author":"Stembridge","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/9.3.367","article-title":"Multiple CYP1B1 mutations and incomplete penetrance in an inbred population segregating primary congenital glaucoma suggest frequent de novo events and a dominant modifier locus","volume":"9","author":"Bejjani","year":"2000","journal-title":"Hum Mol Genet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.04.045","article-title":"Variable expressivity and high penetrance of CYP1B1 mutations associated with primary congenital glaucoma","volume":"116","author":"Suri","year":"2009","journal-title":"Ophthalmology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3109\/13816810.2013.841961","article-title":"CYP1B1 mutations are a major contributor to juvenile-onset open angle glaucoma in Saudi Arabia","volume":"36","author":"Abu-Amero","year":"2015","journal-title":"Ophthalmic Genet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-018-1878-z","article-title":"Congenital glaucoma and CYP1B1: an old story revisited","volume":"138","author":"Alsaif","year":"2019","journal-title":"Hum Genet"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1850762\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:22:45Z","timestamp":1786681365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1850762\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":24,"alternative-id":["10.3389\/fendo.2026.1850762"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1850762","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"article-number":"1850762"}}